Health Literacy in People With Chronic Obstructive Pulmonary Disease

Sponsor
Lovisenberg Diakonale Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03216603
Collaborator
University of Oslo (Other), Norwegian Extra Foundation for Health and Rehabilitation (Other)
130
1
2
38
3.4

Study Details

Study Description

Brief Summary

Health literacy refers to personal and relational factors affecting a person's ability to acquire, understand and use information about health and health services. In a need assessment study it was found that, the health services need to focus on health literacy factors in the follow up of patients with chronic obstructive pulmonary disease (COPD).

Thus, this project evaluate the effect a of a health literacy partnership health promotion intervention (hospital, municipalities, university) after discharge from hospital with the use of motivational interviewing and tailored follow-ups on re-admission, health literacy, self-management quality of life and cost in people with COPD compared with usual care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Health literacy intervention group
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
130 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Health Literacy. An Intervention on Organized Information and Health Care for People With Chronic Obstructive Pulmonary Disease (COPD)
Actual Study Start Date :
Nov 1, 2017
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Health literacy intervention group

Health literacy intervention group will receive self-management help using a motivating interviewing technique delivered by nurses trained on motivating interviewing technique and COPD.

Behavioral: Health literacy intervention group
In the health literacy intervention group all patients will receive self-management help using a motivating interviewing (MI) technique delivered by two MI and COPD trained nurses once a week for eight weeks after hospitalization. Subsequently, the contact between the patients and the nurses will be by follow up motivational telephone calls once a month or more if needed for four months (i.a a total of six months intervention period).

No Intervention: Usual care group

Usual care group will receive usual follow up

Outcome Measures

Primary Outcome Measures

  1. Change of admissions [Eight weeks, six months and one year]

    Number of re-admissions

Secondary Outcome Measures

  1. Change of health literacy [Eight weeks, six months and one year]

    Questionnaire

  2. Change of disease specific quality of life [Eight weeks, six months and one year]

    Questionnaire

  3. Change of e-Health [Eight weeks, six months and one year]

    Questionnaire

  4. Change of physical function [Eight weeks, six months and one year]

    Questionnaire

  5. Change of self-management [Eight weeks, six months and one year]

    Questionnaire

  6. Change of psychological stress [Eight weeks, six months and one year]

    Questionnaire

  7. Change of self-efficacy [Eight weeks, six months and one year]

    Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed with COPD,

  • Above 18 years,

  • Admitted to a medical department at the main intervention hospital, l

  • Live in the sites belonging to the intervention hospital.

Exclusion Criteria:
  • Not diagnosed with COPD,

  • Not above 18 years,

  • Not admitted to a medical department at the main intervention hospital, and

  • Not living in the sites belonging to the intervention hospital.

  • Cognitive failure

  • Patients that are investigated or treated for cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lovisenberg Diakonale Hospital Oslo Norway 0440

Sponsors and Collaborators

  • Lovisenberg Diakonale Hospital
  • University of Oslo
  • Norwegian Extra Foundation for Health and Rehabilitation

Investigators

  • Principal Investigator: Christine Borge, Phd, University of Oslo and Lovisenberg Diaconal Hospital
  • Study Chair: Astrid K. Wahl, Phd, University of Oslo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christine Råheim Borge, Researcher, Lovisenberg Diakonale Hospital
ClinicalTrials.gov Identifier:
NCT03216603
Other Study ID Numbers:
  • 298
First Posted:
Jul 13, 2017
Last Update Posted:
Dec 14, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Christine Råheim Borge, Researcher, Lovisenberg Diakonale Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 14, 2021